An EU agency has recommended a ban on the diabetes drug Avandia, while the U.S. FDA severely restricted its use.
This week on Need to Know: Where art thou, Obama? A look at how Avandia and other possibly dangerous drugs make it to market. And a photojournalist travels to Bangladesh to document one of the world’s most dramatic health crises: childhood malnutrition.
A Need to Know chronology highlighting the history of the controversial diabetes drug Avandia, leading up to a big decision by the FDA on whether to pull it from the shelves.
Dr. Jerome Kassirer, former editor-in-chief of the New England Journal of Medicine, discusses the state of the FDA today, and the conditions that make it possible for drugs like Avandia, which may be pulled from the market, to reach consumers.